CDEK
← All organizations

Astra

For profitContributed to NME

Also known as: Astra USA

Phase 1Phase 2Phase 3Phase 4

Highest phase reached

Phase 4

First clinical trial

Nov 2, 1999

First marketed drug

Nov 18, 1965

First NDA

Nov 18, 1965

Last known activity

Nov 2, 1999

Acquired by AstraZeneca on Jan 1, 1999

Timeline

1910s

  1. Jan 1, 1913

    Astra— Founded

1930s

  1. Jan 1, 1939

    Tika— Acquired

1940s

  1. Jan 1, 1942

    Hassle— Acquired

1980s

  1. Dec 12, 1980

    ritodrine— NDA Organization

  2. Nov 9, 1984

    tocainide— NDA Secondary Org

1990s

  1. Jan 1, 1999

    AstraZeneca— Acquired By

Drugs by trial phase (3 distinct, 10 trials)

Phase 4 (2 own, 0 via acquisition)

Phase 1 (1 own, 0 via acquisition)

Indications

Approved for

Studied for

Marketed drugs (9)

Subsidiaries (2 direct, 2 total across the full acquisition tree)

Recent trials (10)

Details

Founded
Sodertalje, SE Jan 1, 1913
First NDA
Nov 18, 1965
Last known activity
Nov 2, 1999

Designations held

  • Priority review